Gene Therapy and Pharmacogenomics

Basic Principles of Genetic Inheritance

  • Nucleic acids
    • DNA (deoxyribonucleic acid)
    • RNA (ribonucleic acid)
  • Chromosomes
    • Thread-like structures composed of DNA and proteins that carry genetic information.
  • Genes
    • Functional units of heredity located on chromosomes.
  • Alleles
    • Alternative forms of a gene located at the same locus on homologous chromosomes.
    • Dominant allele: expressed even if only one copy is present.
    • Recessive allele: expressed only when two recessive copies are present.
  • Genotype
    • The actual genetic makeup (combination of alleles) of an individual.
  • Phenotype
    • Observable physical or biochemical characteristics determined by genotype and environment.
  • Categories of disease in the context of inheritance
    • Inherited disease: transmitted genetically from parents to offspring.
    • Genetic disease: disorder caused by abnormalities in an individual’s DNA.
    • Acquired disease: develops after birth and is not coded in germ-line DNA.
    • Genetic predisposition: increased likelihood of developing a condition due to inherited genetic factors.

Genetics and Genomics

  • Genetics
    • Study of the structure, function, and inheritance of genes.
  • Heredity
    • Transmission of genetic traits from one generation to the next during reproduction.
  • Genomics
    • Discipline focusing on the collective characterization, quantification, and interaction of genes within an organism.
  • Key molecular components
    • DNA: double-helical molecule containing hereditary information.
    • Chromatin: DNA + histone proteins, packaged to form chromosomes.
    • Four organic bases of DNA
    • Adenine (A)
    • Thymine (T)
    • Guanine (G)
    • Cytosine (C)

Human Genome Project (HGP)

  • Timeline
    • Initiated 19901990; completed 20032003.
  • Accomplishments
    • Identified approximately 30,00030,000 human genes.
    • Sequenced about 3 billion3\,\text{billion} DNA base pairs of the human genome.
    • Catalyzed the development of new bioinformatic tools for genetic data analysis and storage.
  • Significance
    • Created foundational reference for gene-based diagnostics, targeted therapies, and personalized medicine.

Gene Therapy

  • Definition
    • Experimental technique that uses genetic material to treat or prevent disease.
  • Therapeutic strategies
    • Replace a mutated gene with a healthy (wild-type) copy.
    • Introduce a new gene capable of combating disease (e.g., encode therapeutic proteins).
    • Inactivate or “silence” a malfunctioning gene.
  • Gene transfer methods
    • Viral vectors (most common): adenovirus, retrovirus, lentivirus, adeno-associated virus.
    • Non-viral delivery: liposomes, nanoparticles, direct DNA injection.
  • Limitations & risks
    • Viral vectors may cause unintended viral disease or stimulate host immune responses.
    • Proteins produced from artificially introduced genes may be immunogenic.
    • Off-target integration can disrupt normal genes, potentially causing oncogenesis.

Recombinant DNA (rDNA) Technology

  • rDNA: artificially created DNA molecules formed by joining genetic material from multiple sources.
  • Laboratory applications
    • Production of therapeutic proteins: hormones (e.g., insulin, growth hormone), vaccines, antitoxins, monoclonal antibodies.
    • Example: insertion of the human insulin gene into Escherichia coli genome enables large-scale microbial synthesis of recombinant human insulin; currently constitutes the majority of the world’s insulin supply.

Regulatory & Ethical Issues in Gene Therapy

  • NIH Guidelines for Research Involving Recombinant DNA Molecules
    • Eugenics is prohibited: intentional selection of “desirable” genotypes before birth is ethically unacceptable.
    • U.S. federally funded gene-therapy research is restricted to somatic (non-reproductive) cells.
    • Germ-line editing (affecting sperm or ova) is not approved for funding by the NIH.
  • Core ethical principles
    • Respect for autonomy: informed consent must be obtained before genetic manipulation.
    • Beneficence vs. non-maleficence: weigh potential therapeutic benefits against risks such as immune reactions or insertional mutagenesis.
    • Justice: equitable access to gene-based treatments; avoidance of genetic discrimination.

Pharmacogenetics & Pharmacogenomics

  • Pharmacogenetics
    • Study of single-gene variations that modify a drug’s pharmacokinetics (absorption, distribution, metabolism, excretion) or pharmacodynamics (receptor binding, efficacy, toxicity).
  • Pharmacogenomics
    • Broader discipline integrating pharmacology and genomics to understand how the entire genome influences drug response.
    • Goal: individualized or “precision” drug therapy based on a patient’s genetic makeup to maximize efficacy and minimize adverse effects.
  • Practical outcomes
    • Genotype-guided dosing (e.g., warfarin, clopidogrel, codeine via CYP2C9, CYP2C19, CYP2D6 variants).
    • Development of companion diagnostics for targeted cancer therapies (e.g., HER2, EGFR, BRAF).

Nursing Implications

  • Assessment
    • Obtain detailed patient, family, and medication histories, paying special attention to hereditary disorders and previous drug responses.
  • Clinical judgment
    • Identify scenarios where genetic testing may clarify diagnosis, predict drug response, or guide therapy.
    • Be knowledgeable about available genetic resources and referral pathways.
  • Patient education & advocacy
    • Translate complex genetic information into understandable language.
    • Discuss potential benefits, limitations, and ethical considerations of genetic testing.
  • Confidentiality & privacy
    • Protect genetic information from unauthorized disclosure to family members, employers, insurers, or other health professionals.
  • Legal & ethical duties
    • Secure informed consent for genetic testing or participation in gene-based clinical trials.
    • Stay updated on evolving regulations, including the Genetic Information Nondiscrimination Act (GINA).

Audience Response System Questions and Answers

  • Question 1: “Which statement regarding gene therapy is accurate?”
    • Correct answer: The majority of the world’s insulin supply has been produced by recombinant gene technology.
    • Rationale
    • Gene therapy itself is still experimental and not in widespread clinical use.
    • Gene therapy transfers DNA, not RNA.
    • Viruses (not bacteria) are predominantly used as gene-transfer vectors.
  • Question 2: Scenario—patient’s daughter asks about genetic test results.
    • Correct response: Remind the daughter that private information cannot be discussed without the patient’s permission.
    • Rationale
    • Nurses must guard against improper disclosure. Genetic results are protected health information; patient consent is mandatory before sharing with relatives.